This versatility allows for efficient manufacture of personalised medicines, as manufacturers can adapt promptly to changing treatment needs and deliver lesser quantities without compromising cost-effectiveness.Has the validation or solution development staff decided the classification of the raw material? Why or why not?Linked: How the drug expert